Background: Metformin is the drug of first choice in people newly diagnosed with type 2 diabetes. Most patients respond to metformin monotherapy, but many others remain uncontrolled even at maximal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback